Partial liver volume radioembolization induces hypertrophy in the spared hemiliver and no major signs of portal hypertension

HPB

Volumn 16, Issue 3, 2014, Pages 243-249

  Fernández Ros, Nerea ^a   Silva, Nuno ^a   Bilbao, Jose Ignacio ^a   Iñarrairaegui, Mercedes ^a,b   Benito, Alberto ^a   D'Avola, Delia ^a,b   Rodriguez, MacArena ^a   Rotellar, Fernando ^a   Pardo, Fernando ^a   Sangro, Bruno ^a,b  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; ARTIFICIAL EMBOLISM; FEMALE; HUMAN; HYPERSPLENISM; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER HYPERTROPHY; LIVER WEIGHT; MAJOR CLINICAL STUDY; MALE; PARTIAL LIVER VOLUME RADIOEMBOLIZATION; PORTAL HYPERTENSION; PORTAL VEIN THROMBOSIS; SPLEEN; TREATMENT DURATION;

AGED; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; COLORECTAL NEOPLASMS; EMBOLIZATION, THERAPEUTIC; FEMALE; HEPATECTOMY; HUMANS; HYPERTENSION, PORTAL; LIVER NEOPLASMS; LIVER REGENERATION; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; ORGAN SIZE; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84894420465     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/hpb.12095     Document Type: Article

References (38)

1. Ferlay J, Shin H-R, Bray F, Forman D, Mathers C, Parkin DM,. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917.
2. European Association For The Study Of The Liver, European Organisation For Research And Treatment Of Cancer. (2012) EASL-EORTC Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol 56: 908-943.
3. Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunven P, et al. (1990) Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 107: 521-527.
4. Sangro B, Iñarrairaegui M, Bilbao JI,. (2012) Radioembolization for hepatocellular carcinoma. J Hepatol 56: 464-473.
5. Nicolay NH, Berry DP, Sharma RA,. (2009) Liver metastases from colorectal cancer: radioembolization with systemic therapy. Nat Rev Clin Oncol 6: 687-697.
6. Kennedy A, Coldwell D, Sangro B, Wasan H, Salem R,. (2012) Integrating radioembolization into the treatment paradigm for metastatic neuroendocrine tumours in the liver. Am J Clin Oncol 35: 393-398.
7. Kulik LM, Mulcahy MF, Hunter RD, Nemcek AA Jr, Abecassis MM, Salem R,. (2005) Use of yttrium-90 microspheres (TheraSphere) in a patient with unresectable hepatocellular carcinoma leading to liver transplantation: a case report. Liver Transpl 11: 1127-1131.
8. Kulik LM, Atassi B, van, Holsbeeck L, Souman T, Lewandowski RJ, Mulcahy MF, et al. (2006) Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation. J Surg Oncol 94: 572-586.
9. Kim DY, Kwon DS, Salem R, Ma CK, Abouljoud MS,. (2006) Successful embolization of hepatocellular carcinoma with yttrium-90 glass microspheres prior to liver transplantation. J Gastrointest Surg 10: 413-416.
10. Lau WY, Ho SK, Yu SC, Lai EC, Liew CT, Leung TW,. (2004) Salvage surgery following downstaging of unresectable hepatocellular carcinoma. Ann Surg 240: 299-305.
11. Seidensticker R, Seidensticker M, Damm R, Mohnike K, Schutte K, Malfertheiner P, et al. (2012) Hepatic toxicity after radioembolization of the liver using (90)Y-microspheres: sequential lobar versus whole liver approach. Cardiovasc Intervent Radiol 35: 1109-1118.
12. Jakobs TF, Saleem S, Atassi B, Reda E, Lewandowski RJ, Yaghmai V, et al. (2008) Fibrosis, portal hypertension, and hepatic volume changes induced by intra-arterial radiotherapy with 90-yttrium microspheres. Dig Dis Sci 53: 2556-2563.
13. Gulec SA, Pennington K, Hall M, Fong Y,. (2009) Preoperative Y-90 microsphere selective internal radiation treatment for tumour downsizing and future liver remnant recruitment: a novel approach to improving the safety of major hepatic resections. World J Surg Oncol 7: 6.
14. Gaba RC, Lewandowski RJ, Kulik LM, Riaz A, Ibrahim SM, Mulcahy MF, et al. (2009) Radiation lobectomy: preliminary findings of hepatic volumetric response to lobar yttrium-90 radioembolization. Ann Surg Oncol 16: 1587-1596.
15. Ayav A, Habib N, Jiao LR,. (2005) Portal hypertension secondary to 90-yttrium microspheres: an unknown complication. J Clin Oncol 23: 8275-8276.
16. Bilbao JI, Garrastachu P, Herraiz MJ, Rodriguez M, Inarrairaegui M, Rodriguez J, et al. (2010) Safety and efficacy assessment of flow redistribution by occlusion of intrahepatic vessels prior to radioembolization in the treatment of liver tumours. Cardiovasc Intervent Radiol 33: 523-531.
17. 90Y microspheres: angiographic and technical considerations. Cardiovasc Intervent Radiol 30: 571-592.
18. de Baere T, Denys A, Madoff DC,. (2007) Preoperative portal vein embolization: indications and technical considerations. Tech Vasc Interv Radiol 10: 67-78.
19. Abulkhir A, Limongelli P, Healey AJ, Damrah O, Tait P, Jackson J, et al. (2008) Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg 247: 49-57.
20. Madoff DC, Gupta S, Pillsbury EP, Kan Z, Tinkey PT, Stephens LC, et al. (2007) Transarterial versus transhepatic portal vein embolization to induce selective hepatic hypertrophy: a comparative study in swine. J Vasc Interv Radiol 18: 79-93.
21. Smits ML, Vanlangenhove P, Sturm EJ, van den, Bosch MA, Hav M, Praet M, et al. (2012) Transsinusoidal portal vein embolization with ethylene vinyl alcohol copolymer (Onyx): a feasibility study in pigs. Cardiovasc Intervent Radiol 35: 1172-1180.
22. Azoulay D, Castaing D, Krissat J, Smail A, Hargreaves GM, Lemoine A, et al. (2000) Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg 232: 665-672.
23. Kubota K, Makuuchi M, Kusaka K, Kobayashi T, Miki K, Hasegawa K, et al. (1997) Measurement of liver volume and hepatic functional reserve as a guide to decision making in resectional surgery for hepatic tumours. Hepatology 26: 1176-1181.
24. de Graaf W, van den Esschert JW, van Lienden KP, van Gulik TM,. (2009) Induction of tumour growth after preoperative portal vein embolization: is it a real problem? Ann Surg Oncol 16: 423-430.
25. Hayashi S, Baba Y, Ueno K, Nakajo M, Kubo F, Ueno S, et al. (2007) Acceleration of primary liver tumour growth rate in embolized hepatic lobe after portal vein embolization. Acta Radiol 48: 721-727.
26. Elias D, De Baere T, Roche A, Ducreux M, Lecere J, Lasser P,. (1999) During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg 86: 784-788.
27. van Gulik TM, van den Esschert JW, de Graaf W, van Lienden KP, Busch OR, Heger M, et al. (2008) Controversies in the use of portal vein embolization. Dig Surg 25: 436-444.
28. Aoki T, Imamura H, Hasegawa K, Matsukura A, Sano K, Sugawara Y, et al. (2004) Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma. Arch Surg 139: 766-774.
29. Ogata S, Belghiti J, Farges O, Varma D, Sibert A, Vilgrain V,. (2006) Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma. Br J Surg 93: 1091-1098.
30. Moroz P, Anderson JE, Van Hazel G, Gray BN,. (2001) Effect of selective internal radiation therapy and hepatic arterial chemotherapy on normal liver volume and spleen volume. J Surg Oncol 78: 248-252.
31. Goin JE, Salem R, Carr BI, Dancey JE, Soulen MC, Geschwind JF, et al. (2005) Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities. J Vasc Interv Radiol 16: 205-213.
32. Sangro B, Gil-Alzugaray B, Rodriguez J, Sola I, Martinez-Cuesta A, Viudez A, et al. (2008) Liver disease induced by radioembolization of liver tumours: description and possible risk factors. Cancer 112: 1538-1546.
33. Nosher JL, Ohman-Strickland PA, Jabbour S, Narra V, Nosher B,. (2011) Changes in liver and spleen volumes and liver function after radioembolization with yttrium-90 resin microspheres. J Vasc Interv Radiol 22: 1706-1713.
34. 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: technical and methodologic considerations. J Vasc Interv Radiol 17: 1251-1278.
35. Riaz A, Kulik L, Lewandowski RJ, Ryu RK, Giakoumis Spear G, Mulcahy MF, et al. (2009) Radiologic-pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres. Hepatology 49: 1185-1193.
36. Nalesnik MA, Federle M, Buck D, Fontes P, Carr BI,. (2009) Hepatobiliary effects of 90-Yttrium microsphere therapy for unresectable hepatocellular carcinoma. Hum Pathol 40: 125-134.
37. Schweizer W, Duda P, Tanner S, Balsiger D, Hoflin F, Blumgart LH, et al. (1995) Experimental atrophy/hypertrophy complex (AHC) of the liver: portal vein, but not bile duct obstruction, is the main driving force for the development of AHC in the rat. J Hepatol 23: 71-78.
38. Kim RD, Kim JS, Watanabe G, Mohuczy D, Behrns KE,. (2008) Liver regeneration and the atrophy-hypertrophy complex. Semin Interv Radiol 25: 92-103.